Product Information
METRONIDAZOLE 375 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $7.3080 per EA under NDC 62332001850. Its NADAC has been published 115 times since Apr 17, 2024.
The High Outlier badge above means this manufacturer's average price in the metronidazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
375 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332001850
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
1/21/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA079065On Market Since
12/9/2016
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 375 MG CAPSULE has been published 115 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.3080 per EA |
|---|---|
| All-time high | $8.0061 (Apr 16, 2025) |
| All-time low | $6.1014 (Jul 17, 2024) |
| 52-week high | $7.8041 |
| 52-week low | $7.3080 |
| Median price | $7.3080 |
| Average price | $7.2641 |
| Largest weekly change | +12.8% (Nov 20, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the metronidazole market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 375 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 375 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $7.3080 per EA (NDC 62332001850), effective Jun 24, 2026.
How has the price of METRONIDAZOLE 375 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 375 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 375 MG CAPSULE?
Since Apr 17, 2024, the NADAC for METRONIDAZOLE 375 MG CAPSULE has ranged from a low of $6.1014 (Jul 17, 2024) to a high of $8.0061 (Apr 16, 2025), with a median of $7.3080 per EA.
Are there cheaper alternatives to METRONIDAZOLE 375 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of METRONIDAZOLE 375 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures METRONIDAZOLE 375 MG CAPSULE?
METRONIDAZOLE 375 MG CAPSULE (NDC 62332001850) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification